Literature DB >> 3033659

Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

K Yaginuma, Y Shirakata, M Kobayashi, K Koike.   

Abstract

An in vitro system for the production of hepatitis B virus (HBV) particles was established by the transient expression of transfected HBV DNA using a human hepatocellular carcinoma cell, HuH-7, as a recipient. The 3.6- and 2.2-kilobase transcripts observed were similar to those in virus-infected liver cells. Both transcripts revealed the microheterogeneity of their 5' ends. The formation of virus-related particles subsequent to the RNA transcription was demonstrated. The core particles observed in the cytoplasm and the virus particles secreted in the culture medium contained the replicative intermediates of HBV DNA and banded at densities of 1.35-1.36 g/cm3 and 1.22-1.24 g/cm3, respectively. Furthermore, the in vitro mutagenesis of the template HBV DNA demonstrated that the P gene as well as the C gene products were essential for the production of HBV particles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033659      PMCID: PMC304721          DOI: 10.1073/pnas.84.9.2678

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Demonstration of subpopulations of Dane particles.

Authors:  P M Kaplan; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Establishment and some biological characteristics of human hepatoma cell lines.

Authors:  I Dor; M Namba; J Sato
Journal:  Gan       Date:  1975-08

8.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

9.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  113 in total

1.  Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine.

Authors:  T Zhou; J Saputelli; C E Aldrich; M Deslauriers; L D Condreay; W S Mason
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.

Authors:  W E Delaney; T G Miller; H C Isom
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen.

Authors:  T T Yuan; P C Tai; C Shih
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants.

Authors:  D Sitterlin; T H Lee; S Prigent; P Tiollais; J S Butel; C Transy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Coexistence of two distinct secretion mutations (P5T and I97L) in hepatitis B virus core produces a wild-type pattern of secretion.

Authors:  Pong Kian Chua; Yu-Mei Wen; Chiaho Shih
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

Authors:  T Suzuki; N Masui; K Kajino; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Acute hepatitis in rats expressing human hepatitis B virus transgenes.

Authors:  H Takahashi; J Fujimoto; S Hanada; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Establishment and primary application of a mouse model with hepatitis B virus replication.

Authors:  Feng-Jun Liu; Li Liu; Fang He; Su Wang; Tao-You Zhou; Cong Liu; Lin-Yu Deng; Hong Tang
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.